Search by Drug Name or NDC

    NDC 00067-8105-04 Triaminic 5; 2.5 mg/5mL; mg/5mL Details

    Triaminic 5; 2.5 mg/5mL; mg/5mL

    Triaminic is a ORAL SYRUP in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 00067-8105
    Product ID 0067-8105_a7817767-c6af-459c-b807-8a7aac951dea
    Associated GPIs 43995602151210
    GCN Sequence Number 062332
    GCN Sequence Number Description dextromethorphan/phenylephrine LIQUID 5-2.5 MG/5 ORAL
    HIC3 B4L
    HIC3 Description NON-OPIOID ANTITUSSIVE-DECONGESTANT COMBINATIONS
    GCN 98110
    HICL Sequence Number 000395
    HICL Sequence Number Description DEXTROMETHORPHAN HBR/PHENYLEPHRINE HCL
    Brand/Generic Generic
    Proprietary Name Triaminic
    Proprietary Name Suffix Day Time Cold and Cough
    Non-Proprietary Name Dextromethorphan HBr, Phenylephrine HCl
    Product Type HUMAN OTC DRUG
    Dosage Form SYRUP
    Route ORAL
    Active Ingredient Strength 5; 2.5
    Active Ingredient Units mg/5mL; mg/5mL
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2022-12-31

    Package

    NDC 00067-8105-04 (00067810504)

    NDC Package Code 0067-8105-04
    Billing NDC 00067810504
    Package 1 BOTTLE, PLASTIC in 1 CARTON (0067-8105-04) / 118 mL in 1 BOTTLE, PLASTIC
    Marketing Start Date 2012-10-15
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 9437b637-fb70-41dd-8ead-d79698a61e22 Details

    Revised: 12/2020